Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Treatment of Diuretic Resistance with a Novel Percutaneous Blood Flow Regulator: Concept and Initial Experience.

Dierckx R, Vanderheyden M, Heggermont W, Goethals M, Verstreken S, Bartunek J.

J Card Fail. 2019 Aug 30. pii: S1071-9164(19)30623-2. doi: 10.1016/j.cardfail.2019.08.017. [Epub ahead of print]

PMID:
31476373
2.

Impact of non-invasive anatomical testing on optimal medical prescription in patients with suspected coronary artery disease.

Devuyst S, Gigase A, Spapen J, Brouwers S, Couck T, Sonck J, Mizukami T, Gigante C, de Raedt H, Schelfaut D, Heggermont W, De Bruyne B, Penicka M, Van Camp G, Collet C.

Cardiovasc Diagn Ther. 2019 Jun;9(3):221-228. doi: 10.21037/cdt.2019.04.10.

3.

Monitoring reperfused myocardial infarction with delayed left ventricular systolic dysfunction in rabbits by longitudinal imaging.

Feng Y, Hemmeryckx B, Frederix L, Lox M, Wu J, Heggermont W, Lu HR, Gallacher D, Oyen R, Lijnen HR, Ni Y.

Quant Imaging Med Surg. 2018 Sep;8(8):754-769. doi: 10.21037/qims.2018.09.05.

4.

Adherence, knowledge, and perception about oral anticoagulants in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation.

Smet L, Heggermont WA, Goossens E, Eeckloo K, Vander Stichele R, De Potter T, De Backer T.

J Adv Nurs. 2018 Nov;74(11):2577-2587. doi: 10.1111/jan.13780. Epub 2018 Aug 30.

PMID:
29944735
5.

NF-κB-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis.

Remels AHV, Derks WJA, Cillero-Pastor B, Verhees KJP, Kelders MC, Heggermont W, Carai P, Summer G, Ellis SR, de Theije CC, Heeren RMA, Heymans S, Papageorgiou AP, van Bilsen M.

Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2579-2589. doi: 10.1016/j.bbadis.2018.04.022. Epub 2018 May 3.

6.

Technology Advances to Improve Response to Cardiac Resynchronization Therapy: What Clinicians Should Know.

Auricchio A, Heggermont WA.

Rev Esp Cardiol (Engl Ed). 2018 Jun;71(6):477-484. doi: 10.1016/j.rec.2018.01.006. Epub 2018 Feb 14. Review. English, Spanish.

PMID:
29454549
7.

Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation.

Deckx S, Heggermont W, Carai P, Rienks M, Dresselaers T, Himmelreich U, van Leeuwen R, Lommen W, van der Velden J, Gonzalez A, Diez J, Papageorgiou AP, Heymans S.

Matrix Biol. 2018 Mar;66:110-124. doi: 10.1016/j.matbio.2017.09.002. Epub 2017 Sep 25.

PMID:
28958774
8.

Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.

Heggermont WA, Papageorgiou AP, Quaegebeur A, Deckx S, Carai P, Verhesen W, Eelen G, Schoors S, van Leeuwen R, Alekseev S, Elzenaar I, Vinckier S, Pokreisz P, Walravens AS, Gijsbers R, Van Den Haute C, Nickel A, Schroen B, van Bilsen M, Janssens S, Maack C, Pinto Y, Carmeliet P, Heymans S.

Circulation. 2017 Aug 22;136(8):747-761. doi: 10.1161/CIRCULATIONAHA.116.024171. Epub 2017 Jun 13.

PMID:
28611091
9.

Antioxidant Treatment Improves Cardiac Dysfunction in a Murine Model of Premature Aging.

Hemmeryckx B, Hohensinner P, Swinnen M, Heggermont W, Wojta J, Lijnen HR.

J Cardiovasc Pharmacol. 2016 Nov;68(5):374-382.

PMID:
27824722
10.

Metabolic support for the heart: complementary therapy for heart failure?

Heggermont WA, Papageorgiou AP, Heymans S, van Bilsen M.

Eur J Heart Fail. 2016 Dec;18(12):1420-1429. doi: 10.1002/ejhf.678. Epub 2016 Nov 4. Review.

11.

Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience.

Heggermont WA, Goethals M, Dierckx R, Verstreken S, Bartunek J, Vanderheyden M.

Heart Fail Rev. 2016 Nov;21(6):699-701. Review.

PMID:
27620301
12.

Clinical case report: a rare cause of acute kidney failure - tissue is the issue.

Heggermont WA, Verhoef G, Evenepoel P, Sprangers B, Lerut E, Tousseyn T, Claes K.

Acta Clin Belg. 2017 Jun;72(3):201-204. doi: 10.1080/17843286.2016.1178967. Epub 2016 May 17.

PMID:
27253186
13.

Leptin-adiponectin ratio in pre-diabetic patients undergoing percutaneous coronary intervention.

Nguyen PA, Heggermont WA, Vanhaverbeke M, Dubois C, Vydt T, Vörös G, Van Der Schueren B, Overbergh L, Mathieu C, Desmet W, Sinnaeve PR.

Acta Cardiol. 2015 Dec;70(6):640-6. doi: 10.2143/AC.70.6.3120175.

PMID:
26717211
14.

RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection.

Van Aelst LN, Summer G, Li S, Gupta SK, Heggermont W, De Vusser K, Carai P, Naesens M, Van Cleemput J, Van de Werf F, Vanhaecke J, Thum T, Waer M, Papageorgiou AP, Schroen B, Heymans S.

Am J Transplant. 2016 Jan;16(1):99-110. doi: 10.1111/ajt.13421. Epub 2015 Aug 6.

15.

Corrigendum: Fatty acid carbon is essential for dNTP synthesis in endothelial cells.

Schoors S, Bruning U, Missiaen R, Queiroz KC, Borgers G, Elia I, Zecchin A, Cantelmo AR, Christen S, Goveia J, Heggermont W, Goddë L, Vinckier S, Van Veldhoven PP, Eelen G, Schoonjans L, Gerhardt H, Dewerchin M, Baes M, De Bock K, Ghesquière B, Lunt SY, Fendt SM, Carmeliet P.

Nature. 2015 Oct 1;526(7571):144. doi: 10.1038/nature14624. Epub 2015 Aug 5. No abstract available.

PMID:
26245368
16.

The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis.

Corsten MF, Heggermont W, Papageorgiou AP, Deckx S, Tijsma A, Verhesen W, van Leeuwen R, Carai P, Thibaut HJ, Custers K, Summer G, Hazebroek M, Verheyen F, Neyts J, Schroen B, Heymans S.

Eur Heart J. 2015 Nov 7;36(42):2909-19. doi: 10.1093/eurheartj/ehv321. Epub 2015 Jul 22.

PMID:
26206211
17.

Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy.

Singh N, Heggermont W, Fieuws S, Vanhaecke J, Van Cleemput J, De Geest B.

J Heart Lung Transplant. 2015 Nov;34(11):1376-84. doi: 10.1016/j.healun.2015.06.008. Epub 2015 Jun 17.

PMID:
26198441
18.

Liver X receptor activation enhances CVB3 viral replication during myocarditis by stimulating lipogenesis.

Papageorgiou AP, Heggermont W, Rienks M, Carai P, Langouche L, Verhesen W, De Boer RA, Heymans S.

Cardiovasc Res. 2015 Jul 1;107(1):78-88. doi: 10.1093/cvr/cvv157. Epub 2015 May 21.

PMID:
25998987
19.

Fatty acid carbon is essential for dNTP synthesis in endothelial cells.

Schoors S, Bruning U, Missiaen R, Queiroz KC, Borgers G, Elia I, Zecchin A, Cantelmo AR, Christen S, Goveia J, Heggermont W, Goddé L, Vinckier S, Van Veldhoven PP, Eelen G, Schoonjans L, Gerhardt H, Dewerchin M, Baes M, De Bock K, Ghesquière B, Lunt SY, Fendt SM, Carmeliet P.

Nature. 2015 Apr 9;520(7546):192-197. doi: 10.1038/nature14362. Epub 2015 Apr 1. Erratum in: Nature. 2015 Oct 1;526(7571):144.

20.

The RNA-binding protein HuR is essential for the B cell antibody response.

Diaz-Muñoz MD, Bell SE, Fairfax K, Monzon-Casanova E, Cunningham AF, Gonzalez-Porta M, Andrews SR, Bunik VI, Zarnack K, Curk T, Heggermont WA, Heymans S, Gibson GE, Kontoyiannis DL, Ule J, Turner M.

Nat Immunol. 2015 Apr;16(4):415-25. doi: 10.1038/ni.3115. Epub 2015 Feb 23.

21.

A case of HELLP syndrome: an immuno-"logical" approach.

Heggermont WA, Verhelst C, De Wilde K, De Paepe M, Lacquet F, Vonck A.

Acta Clin Belg. 2012 Sep-Oct;67(5):375-7.

PMID:
23189549
22.

MicroRNAs are involved in end-organ damage during hypertension.

Heggermont WA, Heymans S.

Hypertension. 2012 Nov;60(5):1088-93. doi: 10.1161/HYPERTENSIONAHA.111.187104. Epub 2012 Sep 17. Review.

PMID:
22987922
23.

Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.

De Palma AM, Thibaut HJ, van der Linden L, Lanke K, Heggermont W, Ireland S, Andrews R, Arimilli M, Al-Tel TH, De Clercq E, van Kuppeveld F, Neyts J.

Antimicrob Agents Chemother. 2009 May;53(5):1850-7. doi: 10.1128/AAC.00934-08. Epub 2009 Feb 23.

24.

The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.

De Palma AM, Heggermont W, Lanke K, Coutard B, Bergmann M, Monforte AM, Canard B, De Clercq E, Chimirri A, Pürstinger G, Rohayem J, van Kuppeveld F, Neyts J.

J Virol. 2008 May;82(10):4720-30. doi: 10.1128/JVI.01338-07. Epub 2008 Mar 12.

25.

Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles.

De Palma AM, Heggermont W, Leyssen P, Pürstinger G, Wimmer E, De Clercq E, Rao A, Monforte AM, Chimirri A, Neyts J.

Biochem Biophys Res Commun. 2007 Feb 16;353(3):628-32. Epub 2006 Dec 19.

PMID:
17194441

Supplemental Content

Loading ...
Support Center